Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection - Four States, October 2021-January 2022.
作者信息
Roskosky Mellisa, Borah Brian F, DeJonge Peter M, Donovan Catherine V, Blevins Lynn Zanardi, Lafferty Allison G, Pringle Julia C, Kelso Patsy, Temte Jonathan L, Temte Emily, Barlow Shari, Goss Maureen, Uzicanin Amra, Bateman Allen, Florek Kelsey, Kawakami Vance, Lewis James, Loughran Julie, Pogosjans Sargis, Kay Meagan, Duchin Jeff, Lunn Stephanie, Schnitzler Hannah, Arora Shivani, Tate Jacqueline, Ricaldi Jessica, Kirking Hannah
出版信息
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):524-526. doi: 10.15585/mmwr.mm7114a2.
Abstract
摘要
相似文献
1
Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection - Four States, October 2021-January 2022.实地记录：2021年10月至2022年1月期间，四个州有10人在先前感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔变异株90天内感染了奥密克戎变异株
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):524-526. doi: 10.15585/mmwr.mm7114a2.
2
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
3
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
4
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.辉瑞-生物科技 BNT162b2 mRNA 疫苗预防非免疫功能低下 5-17 岁儿童和青少年与 COVID-19 相关的急诊和紧急护理就诊及住院的有效性 - VISION 网络，10 个州，2021 年 4 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 4;71(9):352-358. doi: 10.15585/mmwr.mm7109e3.
5
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.mRNA 疫苗对 COVID-19 相关急诊科和紧急护理就诊以及成人住院的 2 剂和 3 剂效力下降在德尔塔和奥密克戎变异主导期间 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263. doi: 10.15585/mmwr.mm7107e2.
6
SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.SARS-CoV-2 B.1.1.529（奥密克戎）变异株-美国，2021 年 12 月 1 日-8 日。
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734. doi: 10.15585/mmwr.mm7050e1.
7
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体：刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
8
Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.社论：2022 年世界卫生组织（WHO）关于 SARS-CoV-2 奥密克戎变异株（B.1.1.529）的优先推荐意见和应对措施。
Med Sci Monit. 2022 Feb 1;28:e936199. doi: 10.12659/MSM.936199.
9
Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study.自然和诱导免疫对 delta 或 alpha 变异株 SARS-CoV-2 感染发生的保护作用：一项病例对照研究。
BMC Med. 2022 Feb 8;20(1):52. doi: 10.1186/s12916-022-02262-y.
10
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.假型 SARS-CoV-2 变异株奥密克戎的显著免疫逃逸。
Emerg Microbes Infect. 2022 Dec;11(1):1-5. doi: 10.1080/22221751.2021.2017757.
引用本文的文献
1
Factors Associated With Transmission Across Three Waves of SARS-CoV-2 in a Prospective Community-Based Study of Households With School-Aged Children-Dane County, Wisconsin, 2020-2022.与 2020-2022 年威斯康星州戴恩县学龄儿童家庭为基础的前瞻性社区研究中 SARS-CoV-2 经三波传播相关的因素。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70031. doi: 10.1111/irv.70031.
2
SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.2020-2022 年美国伊利诺伊州芝加哥市 HIV 感染者感染 SARS-CoV-2 的风险。
Emerg Infect Dis. 2023 Nov;29(11):2257-2265. doi: 10.3201/eid2911.230577.
3
Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.在墨西哥奥密克戎变异株占主导地位期间，混合免疫对 SARS-CoV-2 再感染和重症 COVID-19 的保护作用。
Front Public Health. 2023 Apr 4;11:1146059. doi: 10.3389/fpubh.2023.1146059. eCollection 2023.
4
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.SARS-CoV-2 引发非无菌免疫，逃避疫苗诱导的免疫：对未来疫苗接种策略的影响。
Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4.
5
Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai, March 7-31, 2022.2022 年 3 月 7 日至 31 日上海奥密克戎变异株流行期间儿童感染 SARS-CoV-2 的流行病学和临床特征。
Influenza Other Respir Viruses. 2022 Nov;16(6):1059-1065. doi: 10.1111/irv.13044. Epub 2022 Aug 31.
6
Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.美国宾夕法尼亚州，非奥密克戎感染 24 天后感染 SARS-CoV-2 奥密克戎变异株 2 型。
Emerg Infect Dis. 2022 Sep;28(9):1911-1913. doi: 10.3201/eid2809.220539. Epub 2022 Aug 1.
本文引用的文献
1
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.既往感染严重急性呼吸综合征冠状病毒2对奥密克戎变异株的防护作用。
N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. Epub 2022 Feb 9.
2
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.SARS-CoV-2 感染和≥18 岁成年人住院情况，按疫苗接种状态，在 SARS-CoV-2 B.1.1.529（奥密克戎）变异株流行之前和期间——加利福尼亚州洛杉矶县，2021 年 11 月 7 日-2022 年 1 月 8 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 4;71(5):177-181. doi: 10.15585/mmwr.mm7105e1.
3
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
4
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.2021 年 5 月至 6 月，美国肯塔基州，新冠疫苗接种后感染 SARS-CoV-2 的再感染风险降低。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1081-1083. doi: 10.15585/mmwr.mm7032e1.
5
COVID-19 reinfection: a rapid systematic review of case reports and case series.COVID-19 再感染：病例报告和病例系列的快速系统评价。
J Investig Med. 2021 Aug;69(6):1253-1255. doi: 10.1136/jim-2021-001853. Epub 2021 May 18.
Zotero 插件